Demonstrated safety with daily subcutaneous (SC) injections of Kineret (R) (Anakinra "C recombinant interleukin-1 receptor antagonist) in a standard practice population Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • July 1, 2003